Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
Recruiting now · Not applicable
Conditions studied: Ischemic Stroke, Transient Ischemic Attack, Atrial Fibrillation, Hypertension, Empowerment
In brief
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
Key facts
- Study ID
- NCT03710902
- Run by
- Jukka Putaala
- People needed
- 405
- Starts
- 2018-10-17
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2025-03-20
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
- Age ≥40 years
- Pre-existing or newly diagnosed hypertension
- Informed consent from the patient or legal representative
You may not qualify if…
- Known high-risk source of cardioembolism
- Known indication for anticoagulation
- Contraindication for anticoagulation
- Pacemaker
- Non-compliance to study interventions as judged by the investigator
- Serious condition hampering the study conduct
Where it is running
- Kanta-Häme Central Hospital — Hämeenlinna, Finland (enrolling)
- Helsinki University Hospital — Helsinki, Finland (enrolling)
- Hyvinkää Hospital — Hyvinkää, Finland (enrolling)
- Päijät-Häme Central Hospital — Lahti, Finland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.